Cinvanti (aprepitant IV) - Heron Therapeutics
Heron Therapeutics: Company Update (Heron Therapeutics) - Jan 7, 2017 - Anticipated NDA submission for CINV in Jan 2017; Anticipated NDA approval in CINV in Q4 2017; Anticipated launch in CINV in Q1 2018 
Anticipated launch • Anticipated NDA Oncology
http://phx.corporate-ir.net/phoenix.zhtml?p=irol-eventDetails&c=115565&eventID=5245663
 
Jan 7, 2017
 
 
ac2223d1-8c6f-4f74-a63e-26233eaf2a7d.jpg